AI-CVD vs DeepRhythmAI
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your primary objective is to perform opportunistic screening for cardiovascular and multisystem diseases using existing CT scans. This platform is ideal for identifying hidden health risks such as coronary artery calcium, aortic calcifications, and cardiac chamber abnormalities without requiring additional imaging or disrupting current clinical workflows. It is best suited for leveraging previously acquired CT data to proactively detect potential cardiac and vascular issues.
View AI-CVD →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your main goal is to enhance the accuracy and efficiency of cardiac arrhythmia detection and classification from ECG data. This AI-powered algorithm is ideal for healthcare providers seeking to revolutionize their ECG analysis process, significantly reduce missed diagnoses of arrhythmias, and streamline reporting workflows. It is best suited for improving diagnostic insights and operational efficiency in the management of patients with suspected or known heart rhythm disorders.
View DeepRhythmAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | DeepRhythmAI |
|---|---|---|
| Pricing | Contact for pricing | Enterprise |
| Deployment | Cloud | Cloud |
| FDA Status | 1 AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepRhythmAIDeepRhythmAI explicitly highlights significant workflow efficiency increases (up to 65%) and faster reporting, along with device-agnostic integration and API availability, suggesting a highly streamlined user experience. While AI-CVD emphasizes no workflow disruption by using existing scans, DeepRhythmAI provides more concrete metrics and features related to ease of use and integration.
Clinical Value
DeepRhythmAIDeepRhythmAI provides a strong, quantifiable claim of reducing missed diagnoses by 14x to 114x, directly impacting patient outcomes through superior accuracy in arrhythmia detection. While AI-CVD offers valuable opportunistic screening for early disease detection, DeepRhythmAI's specific and impactful clinical metric gives it an edge in demonstrated clinical value.
Pricing & Value
TieBoth tools lack transparent pricing information, making a direct comparison of their pricing and value proposition impossible. While both offer significant potential value through efficiency gains and improved diagnostics, the absence of specific cost details prevents a definitive winner.
Enterprise Readiness
DeepRhythmAIDeepRhythmAI demonstrates stronger enterprise readiness with explicit features like API availability, data export capabilities, and a stated target market ranging from solo practices to large health systems. Its established presence with numerous global customers and a founding year of 2005 further indicate a mature and scalable solution.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. AI-CVD's approach to opportunistic, multi-system disease screening using existing CT scans represents a novel paradigm for early detection and resource utilization. DeepRhythmAI's application of advanced CNN and Transformer models trained on an unprecedented 250 billion+ heartbeats for highly accurate arrhythmia detection is equally groundbreaking.
Support & Docs
TieNeither the provided structured facts nor readily available public information explicitly detail the level of customer support or documentation for either AI-CVD or DeepRhythmAI. As both are FDA-cleared products from established companies, it is reasonable to assume standard enterprise-level support is provided, but without specific comparative details, a distinction cannot be made.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | DeepRhythmAI |
|---|---|---|
| Name | AI-CVD | DeepRhythmAI |
| Company | HeartLung Corporation | Medicalgorithmics S.A. |
| Description | AI-CVDu00ae is an FDA-cleared, AI-powered quantitative imaging platform from HeartLung Corporation that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | DeepRhythmAI is an FDA-cleared, cloud-based AI algorithm by Medicalgorithmics S.A. that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. |
| Categories | Cardiology AI | Cardiology AI, Clinical Decision Support & Reference |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology |
| Key Features | Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing | AI-powered arrhythmia detection and classification, Utilizes CNN and Transformer models, Trained on 250 billion+ annotated heartbeats, Device-agnostic and integrates with various ECG devices, Cloud-based software, Faster ECG reporting and analysis, Reduces missed diagnoses (14x to 114x fewer), Streamlines clinical workflows (up to 65% efficiency increase) |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and DeepRhythmAI.